ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2315

Six-Month Effects of a Multimedia Patient Education Tool in Patients with Rheumatoid Arthritis. a Randomized Controlled Trial

Maria A. Lopez-Olivo1, Andrea Barbo2, Tara Rizvi3, Robert Volk4, Heather Lin5 and Maria E. Suarez-Almazor6, 1Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 2Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3Rheumatology, Baylor College of Medicine, Houston, TX, 4Health Services Research, The University of Texas, MD Anderson Cancer Center, Houston, TX, 5Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, 6General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Education, educational innovation, educational research and rheumatoid arthritis (RA), patient, RCT

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: We conducted a multi-centered, open-label, parallel, randomized controlled trial to evaluate the efficacy of a multimedia-patient education tool (MM-PtET) for patients with rheumatoid arthritis (RA) in improving outcomes immediately after the intervention and at 3 and 6 months.

Methods: Patients were recruited from 5 centers and through advertisement. Inclusion criteria were: (i) age ≥18 years (ii) diagnosis of RA by a rheumatologist (iii) disease duration ≤10 years (iii) adequate cognitive status and, (iv) ability to communicate in English or Spanish language. The efficacy of the MM-PtET was evaluated longitudinally using questionnaires on disease knowledge, decisional conflict and role preferences, self-efficacy and disease management before and after viewing the assigned materials, at 3 and 6 months. Linear regression and generalized estimating equation were used in order to determine the effective impact of correlative factors on the efficacy of the MM-PtET, including age, sex, race, education level, language in which the questionnaire was answered, health literacy and disease duration.

Results: 221 participants were randomized (111=MM-PtET, 110=written booklet). Mean age was 51±13 years, mean disease duration was 5±3 years, 85% were female 24% had inadequate health literacy levels and 46% answered the questionnaire in Spanish. 116 (64=MM-PtET, 52=booklet) and 158 (76=MM-PtET, 82=booklet) participants returned their questionnaires at 3 and 6 months, respectively.  Within groups most outcomes were improved from baseline to 3 and 6 months.  At 6 months, participants assigned to the intervention group had statistically significantly higher disease management scores compared to the control group (mean 81.1 vs 76.6, p=0.03).  Greater improvement in knowledge scores from baseline to 6 months were observed in those participants who received the intervention (p=0.03) and those with inadequate health literacy (p=0.006).  Meanwhile, among Whites, the intervention was associated with greater improvements in the decisional conflict scale and uninformed subscale (p=0.004 and p=0.02, respectively); and among males, receiving the intervention group led to improvement in the clarity subscale (p=0.02). Among younger individuals, booklet was associated with improvement in self-efficacy but among older ones, it was MM-PtET (p=0.003). Shorter disease duration, on the other hand, was associated with better disease management (p=0.009). Higher level of education (High School or above) was associated with active role played in health decision-making (p<0.003) after adjusting for correlated outcome data and controlling for other variables.

Conclusion: Our MM-PtET was more effective in improving disease management compared to reading written materials in RA patients at 6 months. The multimedia tool was associated with greater health outcomes improvement among older patients, Whites, and males.  Independent factors associated with improvement include disease duration (shorter) and level of education (at least High School diploma).


Disclosure: M. A. Lopez-Olivo, None; A. Barbo, None; T. Rizvi, None; R. Volk, None; H. Lin, None; M. E. Suarez-Almazor, None.

To cite this abstract in AMA style:

Lopez-Olivo MA, Barbo A, Rizvi T, Volk R, Lin H, Suarez-Almazor ME. Six-Month Effects of a Multimedia Patient Education Tool in Patients with Rheumatoid Arthritis. a Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/six-month-effects-of-a-multimedia-patient-education-tool-in-patients-with-rheumatoid-arthritis-a-randomized-controlled-trial/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/six-month-effects-of-a-multimedia-patient-education-tool-in-patients-with-rheumatoid-arthritis-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology